Galapagos NV ADR (GLPG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GLPG | BMY | AMGN | GSK | GILD |
| Company | Galapagos NV ADR | Bristol-Myers Squibb Company | Amgen Inc | Gsk Plc ADR | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NYSE | NASDAQ |
| Open | 29.15 | 49.16 | 272.14 | 40.66 | 67.09 |
| High | 29.75 | 49.47 | 274.48 | 41.26 | 67.68 |
| Low | 29.15 | 48.96 | 271.05 | 40.60 | 67.00 |
| Last | 29.45 | 48.99 | 273.54 | 41.24 | 67.03 |
| Change | +0.38 | -0.15 | +1.63 | +0.65 | +0.08 |
| % Change | +1.31% | -0.31% | +0.60% | +1.60% | +0.12% |
| Volume | 115,800 | 9,153,200 | 2,493,300 | 2,289,800 | 5,240,200 |
| 20-Day Average Volume | 147,915 | 10,953,850 | 2,216,505 | 2,989,370 | 6,335,325 |
| Previous Close | 29.07 | 49.14 | 271.91 | 40.59 | 66.95 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 30.91 | 50.55 | 271.99 | 41.06 | 69.34 |
| 20-Day Raw Stochastic | 15.07% | 20.04% | 46.12% | 51.29% | 14.18% |
| 20-Day Relative Strength | 25.98% | 41.71% | 48.69% | 50.58% | 32.82% |
| Weighted Alpha | -30.14 | -25.74 | +11.45 | +16.76 | -20.86 |
| Today's Opinion | 100% Sell | 88% Sell | 40% Sell | 56% Buy | 100% Sell |
| Previous Opinion | 100% Sell | 88% Sell | 40% Sell | 40% Buy | 100% Sell |
| Last Month's Opinion | 100% Sell | 24% Sell | 8% Buy | 80% Buy | 88% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.14% since 04/16/24 | +1.51% since 04/16/24 | +2.97% since 04/16/24 | +3.23% since 04/16/24 | -0.42% since 04/16/24 |
| Low | 28.82 on 04/19/24 | 47.62 on 04/18/24 | 260.68 on 04/19/24 | 39.15 on 04/18/24 | 65.90 on 04/18/24 |
| High | 29.75 on 04/23/24 | 49.56 on 04/22/24 | 274.48 on 04/23/24 | 41.26 on 04/23/24 | 67.68 on 04/23/24 |
| 1-Month | |||||
| %Chg | -10.10% since 03/22/24 | -5.66% since 03/22/24 | -0.95% since 03/22/24 | -2.62% since 03/22/24 | -7.68% since 03/22/24 |
| Low | 28.82 on 04/19/24 | 47.62 on 04/18/24 | 260.68 on 04/19/24 | 39.15 on 04/18/24 | 65.90 on 04/18/24 |
| High | 33.00 on 03/27/24 | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 43.45 on 03/25/24 | 73.87 on 03/28/24 |
| 3-Month | |||||
| %Chg | -22.89% since 01/23/24 | -2.25% since 01/23/24 | -11.74% since 01/23/24 | +4.99% since 01/23/24 | -15.66% since 01/23/24 |
| Low | 28.82 on 04/19/24 | 47.58 on 02/06/24 | 260.68 on 04/19/24 | 38.56 on 01/25/24 | 65.90 on 04/18/24 |
| High | 40.34 on 02/20/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 43.84 on 03/07/24 | 81.06 on 01/25/24 |
| 6-Month | |||||
| %Chg | -14.01% since 10/23/23 | -12.52% since 10/23/23 | +0.18% since 10/23/23 | +15.20% since 10/23/23 | -13.58% since 10/23/23 |
| Low | 28.82 on 04/19/24 | 47.58 on 02/06/24 | 249.70 on 10/31/23 | 33.67 on 11/02/23 | 65.90 on 04/18/24 |
| High | 42.46 on 01/08/24 | 56.77 on 10/25/23 | 329.72 on 02/05/24 | 43.84 on 03/07/24 | 87.86 on 01/19/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,940,667 | 99,290,928 | 146,720,288 | 85,467,432 | 83,457,512 |
| Shares Outstanding, K | 65,897 | 2,026,759 | 536,376 | 2,072,440 | 1,245,077 |
| Annual Sales | 259,450,000 | 45,006,000,000 | 28,190,000,000 | 37,725,000,000 | 27,116,000,000 |
| Annual Net Income | 229,120,000 | 8,025,000,000 | 6,717,000,000 | 6,129,940,000 | 5,665,000,000 |
| Last Quarter Sales | 130,640,000 | 11,477,000,000 | 8,196,000,000 | 9,980,060,000 | 7,114,000,000 |
| Last Quarter Net Income | 28,110,000 | 1,762,000,000 | 767,000,000 | 433,200,000 | 1,429,000,000 |
| 60-Month Beta | 0.24 | 0.39 | 0.58 | 0.64 | 0.19 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.42 on 11/03/23 | 1.70 on 02/02/24 | 4.71 on 02/06/24 | 0.72 on 01/31/24 | 1.72 on 02/06/24 |
| Latest Earnings Date | 05/02/24 | 04/25/24 | 05/02/24 | 05/01/24 | 04/25/24 |
| Most Recent Dividend | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.397 on 02/22/24 | 0.770 on 03/14/24 |
| Next Ex-Dividends Date | N/A | 04/04/24 | 05/16/24 | 02/22/24 | 03/14/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 6.55 | 14.58 | 10.54 | 9.96 |